Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 21 - Drugs for disorders of the muscular or neuromuscular system
Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287)
10/2012
10/03/2012CN102702070A Solid form containing (+)-2-[1-(3-oxethyl-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, composition and application thereof
10/03/2012CN102698231A Tablets for tonifying qi and warming channels to relieve rheumatism
10/03/2012CN102698200A Chinese medicinal composition for treating strain and sprain and preparation method thereof
10/03/2012CN102697929A Hydrophilic Chinese medicinal patch and preparation method thereof
10/03/2012CN101522681B Certain chemical entities, compositions and methods
10/02/2012US8278422 Antibodies that specifically bind beta-like glycoprotein hormone polypeptides and heterodimers thereof
10/02/2012CA2546300C 6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors
10/02/2012CA2406393C Soft tissue and bone augmentation and bulking utilizing muscle-derived progenitor cells, compositions and treatments thereof
09/2012
09/27/2012WO2012127392A1 Composition comprising diamine oxidase for use in the treatment or prevention of fibromyalgia or chronic fatigue syndrome
09/27/2012WO2012127382A1 Functional foods comprising diamine oxidase and uses thereof
09/27/2012WO2012127381A1 Topical compositions comprising diaminooxidase for the treatment or prevention of diseases associated with high histamine levels which involve an increase in pain
09/27/2012WO2012097093A3 Novel wnt compositions and therapeutic uses of such compositions
09/27/2012US20120245552 Combination Therapy
09/27/2012US20120245190 Autophagy inducing compound and the uses thereof
09/27/2012US20120245156 Oral lyophilized compositions
09/27/2012US20120245134 Androgen pharmaceutical composition and method for treating depression
09/27/2012US20120245113 Clerodane derivatives for modulation of leukotriene receptor activity and related diseases
09/27/2012US20120245095 Biglycan and related therapeutics and methods of use
09/27/2012US20120245092 Polypeptides having modulatory effects on cells
09/27/2012US20120245088 Compositions comprising igf1 agonists and uses thereof
09/27/2012US20120244216 Coated pharmaceutical capsule dosage form
09/27/2012US20120244213 Methods for the treatment of speech impediments
09/27/2012US20120244069 Human monoclonal antibodies against cd25
09/26/2012EP2501796A1 Recombinant microorganisms
09/26/2012EP2501371A1 Use of hydroxytyrosol for improving muscle differentiation
09/26/2012CN1738618B Pharmaceutical compositions and uses thereof
09/26/2012CN102690278A Novel pyrimidine-fused cyclic compounds as cytokine inhibitors
09/26/2012CN102228452B Honokiol or magnolol or honokiol-magnolol mixed solid lipid nanosphere preparation and preparation method thereof
09/26/2012CN101420943B Chewing composition containing coenzyme q10
09/26/2012CN101282763B Milk derived composition and use to enhance muscle mass or muscle strength
09/25/2012US8273756 Use of modified pyrimidine compounds to promote stem cell migration and proliferation
09/25/2012US8273358 Activatable clostridial toxins
09/25/2012CA2683040C Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride
09/20/2012WO2012125524A1 Compositions and methods for the treatment of musculoskeletal related diseases and disorders using metal ion-citrate analog complexes
09/20/2012WO2012124696A1 Guanidine compound
09/20/2012US20120240247 Jnk3 modulators and methods of use
09/20/2012US20120238629 Addition compounds of guanidinoacetic acid
09/20/2012US20120238592 Use and Application of a Pharmaceutical Composition Containing a Mixture of Natural-Origin Heterocylcial Guanidine
09/20/2012US20120238586 Fatty acid acetylated salicylates and their uses
09/20/2012US20120238577 Prostaglandin transporter inhibitors and uses thereof
09/20/2012US20120238553 Novel benzodioxolyl-oxadiazolyl-diazabicyclononane derivatives and their medical use
09/20/2012US20120238545 Tricyclic pyrazol amine derivatives
09/20/2012US20120238544 Thieno- and furo-pyrimidine modulators of the histamine h4 receptor
09/20/2012US20120238530 Fatty acid acetylated salicylates and their uses
09/20/2012US20120238526 Aconitine compounds, compositions, uses, and preparation thereof
09/20/2012US20120238521 Compositions and Methods for the Treatment of Musculoskeletal Related Diseases and Disorders Using Metal Ion-Citrate Analog Complexes
09/20/2012US20120238515 Methods for preventing or treating sarcopenia and muscle atrophy in animals
09/20/2012US20120237625 Metabolism accelerating composition comprising astragali radix extract
09/20/2012US20120237552 Peptoid Agonists of Nerve Growth Factor and Their Use as Medicaments
09/20/2012US20120237528 Human Tissue Factor Antibody and Uses Thereof
09/20/2012US20120237521 Compositions and methods for increasing muscle growth
09/20/2012US20120237442 Design and Construction of Novel Multivalent Antibodies
09/20/2012CA2830216A1 Compositions and methods for the treatment of musculoskeletal related diseases and disorders using metal ion-citrate analog complexes
09/20/2012CA2830157A1 Guanidine compound
09/19/2012EP2499249A1 Antisense molecules and methods for treating pathologies
09/19/2012CN1771044B Composition for administration of iron for the treatment of restless legs syndrome
09/19/2012CN102675402A 4, 16 beta-diamido-steroid quaternary ammonium salt derivatives, and preparation method and application thereof
09/19/2012CN102675400A 3, 16 beta-diamido-steroid quaternary ammonium salt derivatives, and preparation method and application thereof
09/19/2012CN102675206A Preparation method of novel acetylcholinesterase inhibitor, and activity thereof
09/19/2012CN102671185A Application of scolopendra mutilans neurotoxin peptide omega-SLPTX-Ssmla
09/19/2012CN102671162A Traditional Chinese medicine and preparation method
09/19/2012CN102670912A Group of medicament combined tablets for promoting blood circulation and uniting tendons
09/19/2012CN102670831A Medicinal composition for treating dermatomyositis and preparation method thereof
09/19/2012CN102670501A Orally taken vitamin K1 lipid emulsion
09/19/2012CN102669851A Traditional Chinese medicine mask capable of preventing and treating facial spasm
09/19/2012CN102258531B Medicinal composition containing adenosine cyclophosphate and meglumine and preparation method thereof
09/19/2012CN101796039B Phenylacetic acid compound
09/18/2012US8268833 Inhibitors of histone deacetylase
09/18/2012US8268618 Repressing endogenous CCR5 gene expression in cells using engineered zinc finger proteins
09/18/2012US8268331 Nucleic acid molecules and polypeptides for immune modulation
09/18/2012US8268324 Modified galectin 9 proteins and use thereof
09/18/2012CA2443302C Method for preparing an extract of ginkgo biloba leaves highly enriched in active principles
09/18/2012CA2383136C Obg3 globular head and uses thereof for decreasing body mass
09/13/2012WO2012122414A2 Linear dispensing system with universal escapement
09/13/2012WO2012121403A1 The method of treating amyotrophic lateral sclerosis
09/13/2012WO2012120048A1 Tfeb phosphorylation inhibitors and uses thereof
09/13/2012WO2012120044A1 Tfeb variants and uses thereof
09/13/2012WO2012079057A3 Use of jasmonate for improving skeletal muscle function
09/13/2012US20120232093 Pyrazole derivatives as sigma receptor inhibitors
09/13/2012US20120232072 Imidazopyridine derivatives
09/13/2012US20120232067 Benzodiazepinone compounds and methods of treatment using same
09/13/2012US20120232066 Compositions for reducing risk of adverse events caused by drug-drug interactions
09/13/2012US20120232046 Method and kit for reducing the symptoms of peripheral vascular disease
09/13/2012US20120232022 Botulinum toxin treatments
09/13/2012US20120232004 Methods for Treating Autoimmune Disorders, and Reagents Related Thereto
09/13/2012US20120231085 Controlled release compositions of gamma-hydroxybutyrate
09/13/2012US20120231047 Therapeutic agent delivery for the treatment of asthma via implantable and insertable medical devices
09/13/2012US20120230984 Methods of Treating or Preventing Autoimmune Diseases With 2,4-Pyrimidinediamine Compounds
09/13/2012US20120230911 Tnf-alpha binding proteins
09/13/2012CA2828411A1 Vectors conditionally expressing protein
09/13/2012CA2826864A1 Tfeb variants and uses thereof
09/13/2012CA2826674A1 Tfeb phosphorylation inhibitors and uses thereof
09/12/2012EP2497500A1 Gene therapy for amyotrophic lateral sclerosis and other spinal cord disorders
09/12/2012EP2496227A2 Methods for treating fibromyalgia syndrome
09/12/2012CN102666587A Methods for treatment of muscular dystrophy
09/12/2012CN102659945A Anti-C5aR antibodies and uses thereof
09/12/2012CN102657753A Chinese traditional medicine preparation for treating rheumatoid leg spasm
09/12/2012CN102657694A Quick production process for liquorice extract by high-voltage pulsed electric field
09/12/2012CN102657655A Application of pyrilamine compounds to preparation of acetylcholinesterase inhibitor
09/11/2012US8263121 Solid pharmaceutical preparation
1 ... 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 ... 233